Gary Sharman - Department of Neuroscience, Eli Lilly & Company Limited

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 12 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Development of a Simple Cost Effective Oxygenation System for in Vivo Solution State NMR in 10 Mm NMR Tubes

Peter M. Costa,Daniel H. Lysak,Ronald Soong,Kiera Ronda,William W. Wolff,Katelyn Downey,Katrina Steiner,Vincent Moxley-Paquette,Jacob Pellizzari,Clemens Anklin,Gary Sharman,Carlos Cobas,Santiago Dominguez,Karl J. Jobst,Lindsay Cahill,Myrna J. Simpson,Andre J. Simpson

ANALYTICAL CHEMISTRYno. 31 (2024): 12667-12675

引用0浏览0WOS引用

Mechanism of tau R3 aggregation and inhibition revealed by NMR-based chemical kinetics

Virginia Casablancas-Antras, Sylvain Demanze,Gary Sharman,Caroline Kerridge,Suchira Bose,Andrew J. Baldwin

Biophysical journalno. 3 (2022): 351A-351A

引用0浏览0引用

Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Ao-PrP(C) binding and downstream pathways

James D. Grayson,Matthew P. Baumgartner,Cleide Dos Santos Souza, Samuel J. Dawes,Imane Ghafir El Idrissi,Jennifer C. Louth, Sasha Stimpson,Emma Mead,Charlotte Dunbar,Joanna Wolak,Gary Sharman, David Evans,Anastasia Zhuravleva,Margarita Segovia Roldan,Nicola Antonio Colabufo,Ke Ning,Claire Garwood,James A. Thomas, Benjamin M. Partridge,Antonio de la Vega de Leon, Valerie J. Gillet, Amelia P. Rauter,Beining Chen

CHEMICAL SCIENCEno. 10 (2021): 3768-3785

引用0浏览0引用

Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo-PrPC binding and downstream pathways

Chemical scienceno. 10 (2021): 3768-3785

引用6浏览0WOS引用

A KNIME Workflow for Automated Structure Verification

James A. Lumley,Gary Sharman, Thomas Wilkin, Matthew Hirst,Carlos Cobas, Michael Goebel

SLAS discovery（2020）

引用3浏览0WOS引用

Unlocking the Potential of Late-Stage Functionalisation: an Accurate and Fully Automated Method for the Rapid Characterisation of Multiple Regioisomeric Products

Jeffery Richardson,Gary Sharman,Francisco Martinez-Olid,Santiago Canellas,Jose Enrique Gomez

Reaction chemistry & engineering（2020）

引用5浏览0引用

Quantitative Propagation of Assembled Human Tau from Alzheimer's Disease Brain in Microfluidic Neuronal Cultures

Antigoni Katsikoudi,Elena Ficulle,Annalisa Cavallini,Gary Sharman, Amelie Guyot,Michele Zagnoni,Brian J. Eastwood,Michael Hutton,Suchira Bose

Journal of Biological Chemistry（2020）

引用14浏览0WOS引用

Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer’s disease: synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrPC interactions

Ana M. Matos,Teresa Man, Imane Idrissi,Cleide C. Souza,Emma Mead,Charlotte Dunbar,Joanna Wolak,Maria C. Oliveira,David Evans,James Grayson,Benjamin Partridge,Claire Garwood,Ke Ning,Gary Sharman,Beining Chen,Amélia P. Rauter

PURE AND APPLIED CHEMISTRY（2019）

引用8浏览0引用

GalNAc Mimetics: from Synthesis to Potential Inhibitors in Alzheimer’s Disease

João de Barros,Amélia Rauter,David Evans,Nicolas Dreyfus,Gary Sharman

Proceedings of 5th International Electronic Conference on Medicinal Chemistry (2019)

引用0浏览0引用

Standardization of Analytical Methodology and Procedures for Purity Assessment of Small Molecules in Drug Discovery

Aranzazu Marin,Gary Sharman, Marie Burgess, Christopher Reutter,Alfonso Espada

INSTRUMENTAL METHODS FOR THE ANALYSIS AND IDENTIFICATION OF BIOACTIVE MOLECULES (2014): 125-+

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn